Your browser is no longer supported. Please, upgrade your browser.
Settings
PTN Palatin Technologies, Inc. daily Stock Chart
PTN [NYSE]
Palatin Technologies, Inc.
Index- P/E- EPS (ttm)0.00 Insider Own0.10% Shs Outstand232.87M Perf Week4.73%
Market Cap360.95M Forward P/E13.72 EPS next Y0.11 Insider Trans5.43% Shs Float197.77M Perf Month46.23%
Income0.30M PEG- EPS next Q0.06 Inst Own19.70% Short Float7.43% Perf Quarter95.61%
Sales29.60M P/S12.19 EPS this Y261.40% Inst Trans-2.99% Short Ratio9.38 Perf Half Y86.72%
Book/sh0.10 P/B15.50 EPS next Y650.00% ROA1.10% Target Price4.92 Perf Year30.25%
Cash/sh- P/C- EPS next 5Y- ROE1.70% 52W Range0.59 - 1.74 Perf YTD118.80%
Dividend- P/FCF- EPS past 5Y20.60% ROI76.30% 52W High-10.92% Beta1.88
Dividend %- Quick Ratio5.60 Sales past 5Y478.50% Gross Margin- 52W Low162.71% ATR0.13
Employees19 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)67.10 Volatility15.76% 8.26%
OptionableNo Debt/Eq0.11 EPS Q/Q-295.70% Profit Margin1.20% Rel Volume2.08 Prev Close1.43
ShortableYes LT Debt/Eq0.00 EarningsMay 09 BMO Payout0.00% Avg Volume1.57M Price1.55
Recom- SMA2018.77% SMA5035.86% SMA20066.72% Volume3,254,570 Change8.39%
Jun-05-15Reiterated Canaccord Genuity Buy $4 → $6
Jan-12-15Reiterated ROTH Capital Buy $6 → $4
May-23-12Initiated Noble Financial Buy
Jan-23-07Initiated Next Generation Buy $5
May-20-19 03:48PM  Edited Transcript of PTN earnings conference call or presentation 9-May-19 3:00pm GMT Thomson Reuters StreetEvents +8.39%
May-14-19 08:17AM  What Does Poltronic S.A.'s (WSE:PTN) Balance Sheet Tell Us About It? Simply Wall St.
May-10-19 01:23PM  Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript Motley Fool
May-09-19 09:00AM  Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE
07:30AM  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
May-03-19 04:30PM  Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
Apr-15-19 09:27AM  What Kind Of Share Price Volatility Should You Expect For Palatin Technologies, Inc. (NYSEMKT:PTN)? Simply Wall St.
Apr-05-19 10:46AM  Palatin Technologies (PTN) in Focus: Stock Moves 5.7% Higher Zacks
Apr-04-19 07:30AM  Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases PR Newswire +5.74%
Mar-02-19 08:34AM  The Palatin Technologies Share Price Has Gained 103%, So Why Not Pay It Some Attention? Simply Wall St.
Feb-26-19 07:40AM  Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-12-19 05:20PM  Edited Transcript of PTN earnings conference call or presentation 12-Feb-19 4:00pm GMT Thomson Reuters StreetEvents
07:30AM  Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Feb-06-19 07:30AM  Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019 PR Newswire
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-18-18 12:06PM  Palatin Technologies, Inc. (PTN): Hedge Fund Sentiment Unchanged Insider Monkey
Dec-07-18 02:20PM  Edited Transcript of PTN earnings conference call or presentation 13-Nov-18 4:00pm GMT Thomson Reuters StreetEvents
Nov-27-18 07:40AM  Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-17-18 08:08AM  Heres What Palatin Technologies Incs (NYSEMKT:PTN) P/E Ratio Is Telling Us Simply Wall St.
Nov-13-18 08:11AM  What Kind Of Shareholders Own Palatin Technologies Inc (NYSEMKT:PTN)? Simply Wall St. -12.24%
07:30AM  Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Nov-11-18 08:51AM  Why Palatin Technologies Inc (NYSEMKT:PTN) Looks Like A Quality Company Simply Wall St.
Nov-08-18 07:30AM  Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist PR Newswire
Nov-07-18 04:15PM  Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on November 13, 2018 PR Newswire
Nov-05-18 10:30AM  Earnings Preview: Palatin (PTN) Q1 Earnings Expected to Decline Zacks
Oct-12-18 07:55AM  Recent Analysis Shows Booz Allen Hamilton Holding, j2 Global, Leidos, The Hain Celestial Group, Palatin Technologies, and Marsh & McLennan Companies Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-18-18 10:33PM  Edited Transcript of PTN earnings conference call or presentation 13-Sep-18 3:00pm GMT Thomson Reuters StreetEvents
Sep-13-18 08:01AM  Should You Be Tempted To Buy Poltronic SA (WSE:PTN) Because Of Its PE Ratio? Simply Wall St.
07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
07:08AM  Palatin Technologies Inc (NYSEMKT:PTN): Risks You Need To Consider Before Buying Simply Wall St.
Sep-07-18 04:00PM  Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018 PR Newswire
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-10-18 07:30AM  Analysis: Positioning to Benefit within FIS, Helix Energy, Palatin Technologies, NiSource, Service Corporation International, and Summit Hotel Properties Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jun-25-18 04:56PM  Palatin Technologies Added to Russell 3000® Index PR Newswire -8.48%
08:05AM  Today's Research Reports on Stocks to Watch: 22nd Century Group and Palatin Technologies ACCESSWIRE
Jun-06-18 07:30AM  Stock Performance Review on TherapeuticsMD and Three Other Healthcare Stocks ACCESSWIRE
Jun-04-18 08:03AM  Palatin shares surge 9% premarket after FDA accepts for review treatment for HSDD MarketWatch
07:10AM  Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA PR Newswire
May-29-18 04:53AM  Was Poltronic SA.s (WSE:PTN) Earnings Growth Better Than The Industrys? Simply Wall St.
May-22-18 09:53PM  Edited Transcript of PTN earnings conference call or presentation 15-May-18 3:00pm GMT Thomson Reuters StreetEvents
May-15-18 07:30AM  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 PR Newswire -7.63%
07:23AM  An Intrinsic Calculation For Palatin Technologies Inc (NYSEMKT:PTN) Shows Its 43% Undervalued Simply Wall St.
May-10-18 04:30PM  Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018 PR Newswire
08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within American Homes 4 Rent, Discovery Communications, Vertex Pharmaceuticals, The New York Times, Palatin Technologies, and E*TRADE Financial New Research Emphasizes Economic Growth GlobeNewswire
May-09-18 07:30AM  Palatin Technologies Presents Positive Preclinical MC1 Receptor Agonist Data at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts PR Newswire
May-06-18 10:02AM  Top NasdaqGS Undervalued Stock Simply Wall St.
Apr-19-18 11:50AM  Why Poltronic SA. (WSE:PTN) Delivered An Inferior ROE Compared To The Industry Simply Wall St.
Apr-06-18 02:43PM  HC Wainwright: Why The Upside Potential For Palatin Technologies Is Nearly Fivefold Benzinga
09:29AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Apr-03-18 07:30AM  Palatin Technologies Presents Preclinical Oral Formulation Data on PL-8177, An Investigational Melanocortin Receptor 1 Agonist for Inflammatory Bowel Diseases PR Newswire
Mar-29-18 08:27AM  Does Poltronic SA.s (WSE:PTN) PE Ratio Warrant A Buy? Simply Wall St.
06:47AM  With An ROE Of 242.93%, Has Palatin Technologies Incs (NYSEMKT:PTN) Management Done Well? Simply Wall St.
Mar-26-18 08:00AM  Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women PR Newswire
Mar-21-18 05:50PM  Does Palatin Technologies Incs (NYSEMKT:PTN) PE Ratio Signal A Buying Opportunity? Simply Wall St. +10.89%
Mar-17-18 10:02AM  Cheap Stocks To Watch Out For In March Simply Wall St.
Mar-08-18 07:50AM  Detailed Research: Economic Perspectives on HMS, Colfax, Fossil Group, Palatin Technologies, FIS, and Commercial Metals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-13-18 03:56PM  Edited Transcript of PTN earnings conference call or presentation 12-Feb-18 4:00pm GMT Thomson Reuters StreetEvents +5.76%
Feb-12-18 07:30AM  Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018 PR Newswire
Feb-07-18 04:00PM  Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018 PR Newswire
Feb-05-18 07:30AM  Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist PR Newswire
Jan-05-18 07:20AM  Blog Exposure - FDA Approved Palatins IND Application for PL-8177 as a Potential Treatment for Patients with Ulcerative Colitis ACCESSWIRE
Jan-03-18 07:30AM  Palatin Technologies, Inc. Announces FDA Clearance of Investigational New Drug (IND) Application for PL-8177 For Ulcerative Colitis PR Newswire +10.71%
Dec-26-17 08:02AM  Top Cheap Stocks This Week Simply Wall St.
Nov-22-17 02:15PM  Edited Transcript of PTN earnings conference call or presentation 13-Nov-17 4:00pm GMT Thomson Reuters StreetEvents
Nov-21-17 07:30AM  Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea PR Newswire +11.06%
Nov-16-17 08:03AM  November Top Cheap Stock To Invest In Simply Wall St. +6.84%
Nov-14-17 08:10AM  Recent Analysis Shows Nielsen Holdings, Palatin Technologies, MasTec, Iconix Brand, Eversource Energy, and Booz Allen Hamilton Holding Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire +6.11%
Nov-13-17 07:30AM  Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017 PR Newswire -6.13%
Nov-08-17 04:00PM  Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017 PR Newswire
Oct-31-17 08:24AM  Zacks.com featured highlights: eGain, Streamline Health Solutions, Palatin Technologies, Commercial Vehicle Group and Sibanye Gold Zacks
Oct-30-17 09:42AM  5 Terrific Breakout Stocks Offering Strong Returns Zacks
Oct-05-17 08:39AM  Palatin Technologies (PTN) in Focus: Stock Moves 13.2% Higher Zacks +5.59%
Oct-04-17 07:10AM  Earnings Review and Free Research Report: Neogens Revenue Jumped 14%; Net Income Surged 21% ACCESSWIRE +13.16%
Sep-27-17 04:25PM  Edited Transcript of PTN earnings conference call or presentation 25-Sep-17 3:00pm GMT Thomson Reuters StreetEvents
Sep-26-17 11:02AM  ETFs with exposure to Palatin Technologies, Inc. : September 26, 2017 Capital Cube
Sep-25-17 10:31AM  Investor Network: Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE -9.00%
07:30AM  Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results; Teleconference and Webcast to be held on September 25, 2017 PR Newswire
Sep-20-17 04:15PM  Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2017 Results; Teleconference and Webcast to be held on September 25, 2017 PR Newswire
Sep-12-17 07:30AM  Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors PR Newswire
Sep-06-17 07:30AM  Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories PR Newswire
Aug-12-17 08:45PM  Edited Transcript of PTN earnings conference call or presentation 16-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-16-17 07:30AM  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017 PR Newswire -12.71%
May-11-17 07:30AM  Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017 PR Newswire
Mar-31-17 06:43PM  Palatin Technologies to Present at The MicroCap Conference on April 4th at 1:00 PM ET in New York City at the Essex House Accesswire
Mar-20-17 07:30AM  Palatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women PR Newswire
Mar-09-17 04:00PM  Palatin Technologies To Present At The 29th Annual ROTH Conference PR Newswire
Feb-27-17 08:00AM  AMAG and Palatin Announce Rekynda Data Presentations at the International Society for the Study of Womens Sexual Health Annual Meeting GlobeNewswire
Feb-22-17 11:54AM  Palatin Technologies, Inc. :PTN-US: Earnings Analysis: Q2, 2017 By the Numbers Capital Cube
11:54AM  Palatin Technologies, Inc. :PTN-US: Earnings Analysis: Q2, 2017 By the Numbers
Feb-16-17 01:04PM  PALATIN TECHNOLOGIES INC Financials
11:44AM  AMAG Pharmaceuticals Inks $60M Drug Deal Investopedia
Feb-10-17 04:21PM  PALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
Feb-09-17 08:33AM  PALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
07:30AM  Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February 9, 2017 PR Newswire
07:07AM  Q2 2017 Palatin Technologies Inc Earnings Release - Before Market Open
Feb-03-17 09:19AM  PALATIN TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda PR Newswire
Feb-02-17 10:27AM  Palatin (PTN) Sees Hammer Chart Pattern: Time to Buy? Zacks
Jan-10-17 04:30PM  Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda PR Newswire
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL-3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris ArleneDirectorNov 20Buy0.6912,0008,223288,999Nov 21 12:03 PM
SPANA CARLPresident and CEONov 16Buy0.7920,00015,7664,348,102Nov 19 04:23 PM
WILLS STEPHEN TExecutive VP and CFO/COONov 16Buy0.7720,00015,3563,918,239Nov 19 04:21 PM
DUNTON ALAN WDirectorNov 16Buy0.7810,0007,768422,351Nov 19 04:18 PM
DUNTON ALAN WDirectorNov 15Buy0.80332266412,351Nov 19 04:18 PM